Bright Minds Biosciences Current Ratio Growth & History (DRUG)
Bright Minds Biosciences's current ratio was 36.10 for fiscal 2025.
View full Bright Minds Biosciences company overviewBright Minds Biosciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 36.10 | 24.78 | +218.80% |
| 2024 | 2024-09-30 | 11.32 | −12.93 | −53.32% |
| 2023 | 2023-09-30 | 24.26 | 16.14 | +198.94% |
| 2022 | 2022-09-30 | 8.11 | −23.27 | −74.14% |
| 2021 | 2021-09-30 | 31.38 | — | — |
Bright Minds Biosciences quarterly current ratio
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | 121.97 | 35.41 | +40.91% |
| Q2 2026 | 2026-03-31 | 81.48 | −6.79 | −7.69% |
| Q1 2026 | 2025-12-31 | 57.37 | — | — |
| Q4 2025 | 2025-09-30 | 36.10 | 24.78 | +218.80% |
| Q3 2025 | 2025-06-30 | 86.56 | — | — |
| Q2 2025 | 2025-03-31 | 88.27 | — | — |
| Q4 2024 | 2024-09-30 | 11.32 | −12.93 | −53.32% |
| Q4 2023 | 2023-09-30 | 24.26 | 16.14 | +198.94% |
| Q4 2022 | 2022-09-30 | 8.11 | −23.27 | −74.14% |
| Q4 2021 | 2021-09-30 | 31.38 | — | — |
Bright Minds Biosciences current ratio trends
Between the periods ended 2021-09-30 and 2025-09-30, Bright Minds Biosciences's current ratio increased from 31.38 to 36.10, a change of 4.72. The latest reported quarter, Q3 2026, shows 121.97.
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bright Minds Biosciences source filings ↗